Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 3
2005 4
2006 3
2007 5
2008 9
2009 16
2010 5
2011 10
2012 11
2013 5
2014 5
2015 8
2016 5
2017 7
2018 9
2019 4
2020 14
2021 14
2022 5
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA; RELEVANCE Trial Investigators. Morschhauser F, et al. N Engl J Med. 2018 Sep 6;379(10):934-947. doi: 10.1056/NEJMoa1805104. N Engl J Med. 2018. PMID: 30184451 Free article. Clinical Trial.
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: yamamoto g. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: yamamoto g. Haematologica. 2020 Sep 1;105(9):2308-2315. doi: 10.3324/haematol.2019.231076. Haematologica. 2020. PMID: 33054055 Free PMC article. Clinical Trial.
Aneurysm Infection Caused by Desulfovibrio desulfuricans.
Fujihara T, Kimura K, Matsuo H, Sada RM, Hamaguchi S, Yamamoto G, Yamakura T, Kutsuna S. Fujihara T, et al. Among authors: yamamoto g. Emerg Infect Dis. 2023 Aug;29(8):1680-1681. doi: 10.3201/eid2908.230403. Emerg Infect Dis. 2023. PMID: 37486321 Free PMC article.
Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan.
Haraguchi M, Yamamoto H, Watanabe O, Sakoh T, Ishida K, Ogura S, Katoh-Morishima M, Taya Y, Nishida A, Kaji D, Takagi S, Yamamoto G, Uchida N, Araoka H. Haraguchi M, et al. Among authors: yamamoto g. Bone Marrow Transplant. 2023 Sep;58(9):1051-1053. doi: 10.1038/s41409-023-02019-y. Epub 2023 Jun 17. Bone Marrow Transplant. 2023. PMID: 37330600 Free PMC article. No abstract available.
Factors Associated with Breakthrough Fungemia Caused by Candida, Trichosporon, or Fusarium Species in Patients with Hematological Disorders.
Kimura M, Asano-Mori Y, Sakoh T, Abe M, Ueno K, Hoshino Y, Nakamura S, Umeyama T, Yamagoe S, Miyazaki Y, Baba M, Okada C, Ogura S, Mitsuki T, Yamaguchi K, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Ishiwata K, Takagi S, Yamamoto H, Yamamoto G, Uchida N, Wake A, Taniguchi S, Araoka H. Kimura M, et al. Among authors: yamamoto g. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0208121. doi: 10.1128/AAC.02081-21. Epub 2022 Jan 18. Antimicrob Agents Chemother. 2022. PMID: 35041512 Free PMC article.
Intravenous Zanamivir in Hospitalized Patients With Influenza.
Bradley JS, Blumer JL, Romero JR, Michaels MG, Munoz FM, Kimberlin DW, Pahud B, DeBiasi RL, Yamamoto G, Roberts G, Hossain M, Shortino D, Yates PJ, Adams B, Peppercorn A. Bradley JS, et al. Among authors: yamamoto g. Pediatrics. 2017 Nov;140(5):e20162727. doi: 10.1542/peds.2016-2727. Pediatrics. 2017. PMID: 29051331 Clinical Trial.
Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies.
Sakoh T, Kimura M, Takagi S, Ogura S, Morishima M, Yamamuro R, Yamaguchi K, Yuasa M, Kaji D, Kageyama K, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Wake A, Uchida N, Taniguchi S, Araoka H. Sakoh T, et al. Among authors: yamamoto g. Ann Hematol. 2023 May;102(5):1239-1246. doi: 10.1007/s00277-023-05185-7. Epub 2023 Mar 27. Ann Hematol. 2023. PMID: 36971808 Clinical Trial.
Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M, Araoka H, Yamamoto H, Nakamura S, Nagi M, Yamagoe S, Miyazaki Y, Ogura S, Mitsuki T, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Shimazu H, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A. Kimura M, et al. Among authors: yamamoto g. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02183-17. doi: 10.1128/AAC.02183-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29530846 Free PMC article.
137 results